Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CSII - Cardiovascular completes enrollment in coronary treatment trial


CSII - Cardiovascular completes enrollment in coronary treatment trial

2023-04-03 16:40:24 ET

  • Cardiovascular Systems ( NASDAQ: CSII ) said it had completed the enrollment of its 2,000 patient in the Eclipse coronary atherectomy trial.
  • The results from the are expected to be shared in the fall of 2024.
  • Coronary atherectomy is a minimally invasive procedure to remove blockage from coronary arteries to improve blood flow to the heart.
  • Press Release

For further details see:

Cardiovascular completes enrollment in coronary treatment trial
Stock Information

Company Name: Cardiovascular Systems Inc.
Stock Symbol: CSII
Market: NASDAQ
Website: csi360.com

Menu

CSII CSII Quote CSII Short CSII News CSII Articles CSII Message Board
Get CSII Alerts

News, Short Squeeze, Breakout and More Instantly...